Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 2, 2006, Pages 492-499

  Bekelman, Justin E ^a   Rosenzweig, Kenneth E ^a   Bach, Peter B ^a   Schrag, Deborah ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Health services research; Non small cell lung cancer; Postoperative radiotherapy; Practice patterns; SEER

Indexed keywords

DATA ACQUISITION; DISEASE CONTROL; PATIENT TREATMENT; TUMORS; UNCERTAIN SYSTEMS;

HEALTH SERVICES RESEARCH; NON-SMALL-CELL LUNG CANCER; POSTOPERATIVE RADIOTHERAPY; PRACTICE PATTERNS; SEER;

RADIOTHERAPY;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; DEMOGRAPHY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; META ANALYSIS; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; POSTOPERATIVE RADIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT FAILURE; UNCERTAINTY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; SEER PROGRAM;

EID: 33748286679     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.04.032     Document Type: Article

References (25)

1. Paterson R., and Russell M.H. Clinical trials in malignant disease. Part IV-lung cancer. Value of postoperative radiotherapy. Clin Radiol 13 (1962) 141-144
2. Wagner H. Postoperative adjuvant therapy for patients with resected non-small cell lung cancer: still controversial after all these years. Chest 117 (2000) 110S-118S
3. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352 (1998) 257-263
4. Bonner J.A., Tincher S.A., and Fiveash J.B. Balancing the possible effectiveness of postoperative radiotherapy for non-small-cell lung cancer against the possible detriment of radiation-induced toxicity. J Clin Oncol 19 (2001) 3905-3907
5. Movsas B. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer. Oncology 15 (2001) 1549-1558
6. Machtay M., Kaiser L.R., and Glatstein E. Is meta-analysis really meta-physics?. Chest 116 (1999) 539-542
7. Ettinger D.S., and Kris M.G. NCCN Practice Guidelines Panel: non-small cell lung cancer. Cancer Control 8 (2001) 22-31
8. Weisenburger T.H., Graham M.V., Sause W.T., et al., American College of Radiology. Postoperative radiotherapy in non-small cell lung cancer. ACR appropriateness criteria. Radiology 215 Suppl (2000) 1295-1318
9. Okawara G., Ung Y.C., Markman B.R., et al. Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline. [see comment]. Lung Cancer 44 (2004) 1-11
10. Logan D.M., Lochrin C.A., Darling G., et al., Provincial Lung Cancer Disease Site Group. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Cancer Prev Control 1 (1997) 366-378
11. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 13 Regs Public-Use, Nov 2004 Sub (1973-2002 varying), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission.
12. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th edition (2002), Springer-Verlag, New York
13. World Health Organization. International Classification of Disease for Oncology. (Ed 3) (2000), World Health Organization, Geneva, Switzerland
14. The NCCN Non-Small-Cell Lung Cancer Clinical Practice Guidelines in Oncology, version (1.1999). ©National Comprehensive Cancer Network, Inc. Available courtesy of the NCCN.
15. The NCCN Non-Small-Cell Lung Cancer Clinical Practice Guidelines in Oncology (Version 1.2000), The Complete Library of NCCN Clinical Practice Guidelines in Oncology [CD-ROM] (June 2000) (2000), ©National Comprehensive Cancer Network, Jenkintown, PA
16. Weisenburger T.H., Graham M.V., Sause W.T., et al. Postoperative radiotherapy in non-small cell lung cancer. ACR Appropriateness Criteria (1996), American College of Radiology, Reston, VA
17. The NCCN Non-Small-Cell Lung Cancer Clinical Practice Guidelines in Oncology (Version 2.2006), The Complete Library of NCCN Clinical Practice Guidelines in Oncology (2006), ©National Comprehensive Cancer Network, Jenkintown, PA
18. Author estimate of US Medicare combined physician and hospital reimbursement for conventional postoperative radiotherapy for NSCLC based on 2006 National Average Fee Schedules and Ambulatory Payment Classification rates.
19. Movsas B. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer. Oncology 16 (2002) 90-95
20. Arriagada R., Bergman B., Dunant A., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
21. Blum R.H. Adjuvant chemotherapy for lung cancer-a new standard of care. N Engl J Med 350 (2004) 404-405
22. Bach P.B. Using practice guidelines to assess cancer care quality. J Clin Oncol (2005) 9041-9043
23. Hofmann H.S., Taege C., Lautenschlager C., et al. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer. Eur J Cardio-Thorac Surg 21 (2002) 606-610
24. Snijder R.J., Brutel de la Riviere A., Elbers H.J., et al. Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin. Ann Thorac Surg 65 (1998) 212-216
25. Ghiribelli C., Voltolini L., Paladini P., et al. Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump. Eur J Cardio-Thorac Surg 16 (1999) 555-559